Physician profile
Edwin Aquino
NPI 1174596720
$371.75
in general payments reported to CMS, 2019-2025
9 companies · $70.60 in 2025
The $70.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.76 · 2020: $22.98 · 2021: $38.51 · 2022: $67.29 · 2023: $148 · 2025: $70.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $147.61 | 2023 | |
| Averitas Pharma INC. | $70.60 | 2025 | Qutenza |
| Janssen Pharmaceuticals, INC | $39.68 | 2021-2022 | |
| Novo Nordisk INC | $35.54 | 2020-2022 | |
| Amgen INC. | $27.45 | 2021-2022 | |
| Lilly USA, LLC | $13.16 | 2022 | |
| Boston Scientific Corporation | $13.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.95 | 2022 | |
| Endo Pharmaceuticals INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Aquino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.